Bacillus Calmette-Guerin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-γ, which Inhibits B16F10 melanoma cell growth in vitro

Cancer Immunology Immunotherapy

Volumn 42, Issue 5, 1996, Pages 280-284

  Fujimoto, Toshihiro ^a   O'Donnell, Michael A ^a   Szilvasi, Akos ^a   Yang, Hua ^a   Duda, Rosemary B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

BCG; GM CSF; IFN ; IL 2; Melanoma

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT BCG VACCINE; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERLEUKIN 2; RECOMBINANT PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; EXPERIMENTAL MELANOMA; FEMALE; IMMUNOLOGY; MOUSE;

ANIMALS; BCG VACCINE; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; INTERLEUKIN-2; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0029665608     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050283     Document Type: Article

References (25)

1. Abdel-Wahab ZA, Osanto S, Darrow TL, Barber JR, Vervaert CE, Gangavalli R, McCallister TJ, Siegler HF (1994) Transduction of human melanoma cells with gamma interferon gene enhances cellular immunity. Cancer Gene Ther 1:171
2. Brouckaert PGG, Leroux-Roels GG, Guisez, Y, Tavernier J, Fiers W (1986) In vivo anti-tumour activity of recombinant human and murine TNF. alone and in combination with murine IFN-γ, on a syngeneic murine melanoma. Int J Cancer 38:763
3. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258
4. Collart MA, Belin D, Vassalli JD, Kossodo S, Vassalli P (1986) γ-Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 164:2113
5. Czarnetzki BM, Macher E, Suciu S, Thomas D, Steerenberg PA, Rümke P (1993) Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781). Eur J Cancer 29A:1237
6. Dalton DK, Pitts-meek S, Keshav S, Figari IS, Bradley A, Stewart TA (1993) Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739
7. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophuge colony-stimulating factor stimulates potent, specific, and long-tasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539
8. Haanen JBAG, Malefijt RW, Res PCM, Kraakman EM, Ottenhoff THM, Vries RRP, Spits H (1991) Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 174:583
9. Horikoshi T, Fukuza K, Hanada N, Ezoe K, Eguchi H, Hamaoka S, Tsujiya H, Tsukamoto T (1995) In vitro comparative study of the antitumor effects of human interteron-alpha, beta and gamma on the growth and invasive potential of human melanoma cells. J Dermatol 22:631
10. Huygen K, Abramowics D, Vandenbussche P, Jacobs F, Bruyn J, Kentos A, Drowart A, Vooren JPV, Goldman M (1992) Spleen cell cytokine secretion in mycobacterium bovis BCG-infected mice. Infect Immun 60:2880
11. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman M (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693
12. Lamm DL, Reichert DF, Harris SC, Lucio RM (1982) Immunotherapy of murine transitional cell carcinoma. J Urol 128:1104
13. Morton DL, Foshag LJ, Hoon DSB, Nizze JA, Wanek LA, Chang C, Davtyan DG, Gupta RK, Elashoff R, Irie RF (1992) Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 216:463
14. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. J Immunol Methods 65:55
15. Murray HW (1988) Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med 108:595
16. Murray PJ, Aldovini A, Young RA (1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci USA 93:934
17. NIH Guide for the Care and Use of Laboratory Animals. NIH Publication # 86-23 (1985) Washington DC 20402, USA
18. O'Donnell MA, Aldovini A, Duda RB, Yang H, Szilvasi A, Young RA, DeWolf WC (1994) Recombinant mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 62:508
19. Orme IM (1993) Immunity to mycobacteria. Curr Opin Immunol 5:497
20. Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76:241
21. Ruggiero V, Tavernier J, Fiers W, Baglioni C (1986) Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J Immunol 136:2445
22. Shapiro A, Lijovetzky G, Pede D (1988) Changes of the mucosal architecture and of urine cytology during BCG treatment. World J Urol 6:61
23. Tan JK, Ho VC (1993) Pooled analysis of the efficacy of bacille Calmette-Guérin (BCG) immunotherapy in malignant melanoma. J Dermatol Surg Oncol 19:985
24. Wing EJ, Magee DM, Whiteside TL, Kaplan SS, Shadduck RK (1989) Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor α and interferon in cancer patients. Blood 73:643
25. Yamamoto N, Zou JP, Li XF, Takenaka H, Noda S, Fujii T, Ono S, Kobayashi Y, Mukaida N, Matsushima K, Fujiwara H, Hamaoka T (1995) Regulatory mechanisms for production of IFN-γ and TNF by antitumor T cells or macrophages in the tumor-bearing state. J Immunol 154:2281